Investor Relations

Latest Financial Results

Q3 2023

Quarter Ended Sep 30, 2023

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2022

Company Overview

BullFrog AI, an emerging digital biopharma company, is committed to changing that paradigm.

Using our proprietary AI/ML analytics platform, we aim to improve drug development and clinical trials through identification of high-value data niches and patient subgroups. This will ultimately lead to improved clinical outcomes for patients, and reduction of trial-and-error treatment strategies in our disease areas of focus.

Our mission is to improve lives by identifying critical connections between therapies and highly responsive patients – in less time, with less cost, and more precision.

Stock Snapshot

IR Contacts

Headquarters

BullFrog AI Holdings, Inc.
325 Ellington Blvd.
#317
Gaithesburg, MD 20878
T: 240-658-6710
info@bullfrogai.com

Investor Relations

RedChip Companies Inc.
Todd McKnight
VP Investor Relations
431 E Horatio Ave
Suite #100
Maitland, FL 32751
T: 407.571.0904
Todd@redchip.com

Transfer Agent

VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
F: 646-536-3179
0-K@vstocktransfer.com